192 related articles for article (PubMed ID: 21261996)
1. Identification and regulation of c-Myb target genes in MCF-7 cells.
Quintana AM; Liu F; O'Rourke JP; Ness SA
BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996
[TBL] [Abstract][Full Text] [Related]
2. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
[TBL] [Abstract][Full Text] [Related]
4. MYB suppresses differentiation and apoptosis of human breast cancer cells.
Drabsch Y; Robert RG; Gonda TJ
Breast Cancer Res; 2010; 12(4):R55. PubMed ID: 20659323
[TBL] [Abstract][Full Text] [Related]
5. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
6. Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.
Pieraccioli M; Imbastari F; Antonov A; Melino G; Raschellà G
Cell Cycle; 2013 Jul; 12(14):2309-20. PubMed ID: 24067373
[TBL] [Abstract][Full Text] [Related]
7. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
[TBL] [Abstract][Full Text] [Related]
8. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
9. SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.
Hammerich-Hille S; Kaipparettu BA; Tsimelzon A; Creighton CJ; Jiang S; Polo JM; Melnick A; Meyer R; Oesterreich S
J Biol Chem; 2010 Feb; 285(6):3608-3616. PubMed ID: 19901029
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
11. β-Estradiol-dependent activation of the JAK/STAT pathway requires p/CIP and CARM1.
Coughlan N; Thillainadesan G; Andrews J; Isovic M; Torchia J
Biochim Biophys Acta; 2013 Jun; 1833(6):1463-75. PubMed ID: 23434684
[TBL] [Abstract][Full Text] [Related]
12. Dramatic repositioning of c-Myb to different promoters during the cell cycle observed by combining cell sorting with chromatin immunoprecipitation.
Quintana AM; Zhou YE; Pena JJ; O'Rourke JP; Ness SA
PLoS One; 2011 Feb; 6(2):e17362. PubMed ID: 21364958
[TBL] [Abstract][Full Text] [Related]
13. Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines.
Diller M; Schüler S; Buchholz S; Lattrich C; Treeck O; Ortmann O
Maturitas; 2014 Apr; 77(4):336-43. PubMed ID: 24529907
[TBL] [Abstract][Full Text] [Related]
14. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.
Zhao H; Kalota A; Jin S; Gewirtz AM
Blood; 2009 Jan; 113(3):505-16. PubMed ID: 18818396
[TBL] [Abstract][Full Text] [Related]
15. Revisiting a selection of target genes for the hematopoietic transcription factor c-Myb using chromatin immunoprecipitation and c-Myb knockdown.
Berge T; Matre V; Brendeford EM; Saether T; Lüscher B; Gabrielsen OS
Blood Cells Mol Dis; 2007; 39(3):278-86. PubMed ID: 17587615
[TBL] [Abstract][Full Text] [Related]
16. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
17. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
Chen L; Xu S; Zeng X; Li J; Yin W; Chen Y; Shao Z; Jin W
Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):1-7. PubMed ID: 20043041
[TBL] [Abstract][Full Text] [Related]
18. Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.
Tanno B; Sesti F; Cesi V; Bossi G; Ferrari-Amorotti G; Bussolari R; Tirindelli D; Calabretta B; Raschellà G
J Biol Chem; 2010 Sep; 285(38):29434-45. PubMed ID: 20622260
[TBL] [Abstract][Full Text] [Related]
19. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]